PR Newswire Clinical TrialsOriginal article
RyMed Technologies Announces New Study Highlighting Superiority of Antibacterial-Impregnated Needleless Connectors against Multidrug-Resistant "SUPERBUGS"
ConferencepositiveInVision-Plus CS®Positive
AI Analysis
Summary
RyMed Technologies announced independent laboratory study results showing InVision-Plus CS® antibacterial needleless connectors achieved 36-fold higher microbial kill efficiency against VRE compared to standard connectors. The data will be presented at AVA 2026.
Outcome Details
36-fold higher microbial kill efficiency against VRE compared to standard silicone connectors
Importance:4/10
Sentiment:
0.70
medical deviceinfection preventionlaboratory testingantimicrobialconference presentation
Read the original article
Published by PR Newswire Clinical Trials on July 24, 2026 6:00 PM
